Luoxin Pharmaceuticals Group Stock Co Ltd (002793) — Financial Flexibility Index
Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥98.10 Million (operating CF CN¥90.75 Million minus capex CN¥7.34 Million) represents 0% of total liabilities (CN¥2.46 Billion). Check Luoxin Pharmaceuticals Group Stock Co Lt total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Luoxin Pharmaceuticals Group Stock Co Ltd Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Luoxin Pharmaceuticals Group Stock Co Ltd across 15 annual periods. For the full cash flow conversion analysis, see Luoxin Pharmaceuticals Group Stock Co Lt (002793) cash conversion ratio.
Annual Financial Flexibility Index for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2025)
Year-by-year free cash flow to debt coverage for Luoxin Pharmaceuticals Group Stock Co Ltd. Explore cash flow to debt ratio of Luoxin Pharmaceuticals Group Stock Co Lt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.11x | CN¥285.25 Million | CN¥253.07 Million | CN¥2.49 Billion | ▲ +875.6% |
| 2024 | -0.01x | CN¥-42.50 Million | CN¥-157.85 Million | CN¥2.88 Billion | ▼ -104.7% |
| 2023 | 0.31x | CN¥795.18 Million | CN¥552.79 Million | CN¥2.54 Billion | ▲ +301.6% |
| 2022 | -0.16x | CN¥-744.31 Million | CN¥-939.13 Million | CN¥4.80 Billion | ▼ -271.8% |
| 2021 | 0.09x | CN¥429.66 Million | CN¥120.63 Million | CN¥4.76 Billion | ▼ -7.3% |
| 2020 | 0.10x | CN¥328.36 Million | CN¥-32.40 Million | CN¥3.37 Billion | ▼ -51.1% |
| 2019 | 0.20x | CN¥696.91 Million | CN¥116.33 Million | CN¥3.50 Billion | ▼ -67.6% |
| 2018 | 0.61x | CN¥301.99 Million | CN¥114.12 Million | CN¥491.85 Million | ▼ -66.3% |
| 2017 | 1.82x | CN¥263.34 Million | CN¥102.27 Million | CN¥144.74 Million | ▲ +45.0% |
| 2016 | 1.25x | CN¥143.75 Million | CN¥72.74 Million | CN¥114.56 Million | ▲ +164.0% |
| 2015 | 0.48x | CN¥99.85 Million | CN¥58.12 Million | CN¥210.10 Million | ▼ -35.4% |
| 2014 | 0.74x | CN¥97.41 Million | CN¥41.83 Million | CN¥132.40 Million | ▼ -2.3% |
| 2013 | 0.75x | CN¥84.23 Million | CN¥64.75 Million | CN¥111.80 Million | ▲ +10.0% |
| 2012 | 0.69x | CN¥114.28 Million | CN¥33.31 Million | CN¥166.77 Million | ▲ +17.8% |
| 2011 | 0.58x | CN¥69.84 Million | CN¥46.53 Million | CN¥120.07 Million | — |